RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SPINA M
Collezione AO Cuneo

Items : 4

Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi. in Annals of hematology / Ann Hematol. 2021 Oct;100(10):2547-2556. doi: 10.1007/s00277-021-04604-x. Epub 2021 Jul 30.

2021
AO Cuneo

Ciammella P; Ghiggi C; Gallamini A; Sorasio R; Balzarotti M; Giordano L; Chimienti E; Rodari M; Liberati AM; Fabbri A; Ricci F; Bonfichi M; Kovalchuk S; Pulsoni A; Musso M; Palombi F; Consoli U; Carella M; Specchia G; Califano C; Spina M; Mazza R; Santoro A; Ricardi U; Chauvie S; Carlo-Stella C; Merli F;

Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma. in Oncotarget / Oncotarget. 2018 May 4;9(34):23443-23450. doi: 10.18632/oncotarget.25215. eCollection 2018 May 4.

2018
AO Cuneo
AOU Città della Salute di Torino

Zinzani PL; Trentin L; Morello L; Argnani L; Desabbata G; Scortechini I; Castellino C; Mastrullo L; Marasca R; Santambrogio E; Vanazzi A; D'Alò F; Rigolin GM; Ilariucci F; Molica S; Cascavilla N; Tosi P; Di Renzo N; Baldini L; Zilioli VR; Paolini R; Visco C; Merli M; Pisani F; Spina F; Ferrero S; Volpetti S; Spina M; Gotti M; et alii...

The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL). in American journal of hematology / Am J Hematol. 2015 Jun;90(6):499-503. doi: 10.1002/ajh.23994. Epub 2015 May 10.

2015
AO Cuneo
AOU Città della Salute di Torino

Bosi A; Gotti M; Rosaria S; Maria SP; Levis A; Stefoni V; Vitolo U; Spina M; Stelitano C; Balzarotti M; Castagnoli A; Merli F; Zinzani PL; Biggi A; Rigacci L; Puccini B; Gallamini A;

Lack of prognostic value for peripheral absolute monocyte count in a population of diffuse large b-cell lymphoma in the rituximab era in Hematological Oncology

2015
AO Cuneo
AOU Città della Salute di Torino

Aprile Von Hohenstaufen K; Gulden-Sala W; Margiotta-Casaluci G; Franceschetti S; Moccia AA; Bertoni F; Cavalli F; Stathis A; Ghielmini M; Stussi G; Zucca E; Gaidano G; Conconi A; Canepari M; Gonella A; Castellino C; Sorasio R; Bonferroni M; Mattei D; Mordini N; Borra A; Rapezzi D; Margaria F; Conte E; Celeghini I; Bertolotti L; Fiore F; Grasso M; Ciammella P; et alii...